2. Academic Validation
  3. ACSS2/AATF Drives Soluble FasL-Mediated CD8+ T Cell Apoptosis in Pancreatic Neuroendocrine Tumors

ACSS2/AATF Drives Soluble FasL-Mediated CD8+ T Cell Apoptosis in Pancreatic Neuroendocrine Tumors

  • Adv Sci (Weinh). 2025 Aug 12:e06883. doi: 10.1002/advs.202506883.
Qin Dang 1 2 3 4 5,  Ting Wang 1 2 3 4 5,  Yan Wang 1 2 3 4 5,  Zeng Ye 1 2 3 4 5,  Borui Li 6 7,  Xuan Pan 8,  Zheng Li 1 2 3 4 5,  Guixiong Fan 1 2 3 4 5,  Desheng Jing 1 2 3 4 5,  Junfeng Xu 1 2 3 4 5,  Qiangsheng Hu 9,  Shunrong Ji 1 2 3 4 5,  Xiaowu Xu 1 2 3 4 5,  Xianjun Yu 1 2 3 4 5,  Yi Qin 1 2 3 4 5
Affiliations

Affiliations

  • 1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • 2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • 3 Shanghai Pancreatic Cancer Institute, Shanghai, 200032, China.
  • 4 Shanghai Key Laboratory of Precision Medicine for Pancreatic Cancer, Shanghai, 200032, China.
  • 5 Pancreatic Cancer Institute, Fudan University, Shanghai, 200032, China.
  • 6 Department of Hepatopancreatobilary Surgery, the First College of Clinical Medical Science, Three Gorges University, Yichang, Hubei, 443001, China.
  • 7 The People's Hospital of China Three Gorges University, Yichang, Hubei, 443001, China.
  • 8 Department of Hepatobiliary Surgery, Yijishan Hospital, The First Affiliated Hospital of Wannan Medical College, Wuhu, 241001, China.
  • 9 Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, China.
PMID: 40791180 DOI: 10.1002/advs.202506883
Abstract

Besides the traditional carbon sources, Acetyl coenzyme A has recently been shown to be generated from acetate in various cancers, which subsequently promotes tumor growth and immune escape. However, the mechanism of Acetyl coenzyme A availability in pancreatic neuroendocrine tumors (PNETs) remains largely unknown. Herein, the metabolic-epigenetic modification driven by acetyl coenzyme A synthase 2 (ACSS2) and its effect on the Fas/FasL system in PNETs is investigated. ACSS2 is highly expressed in PNETs and significantly correlated with patient prognosis. Mechanistically, ACSS2 activity or acetate supplementation induces histone H3/H4 hyperacetylated in PNET cells. This epigenetic modification recruits the transcription factor AATF to co-regulate FasL transcription, specifically enhancing soluble FasL secretion. Secreted FasL binds Fas receptors on CD8+ T cells, activating Caspase-8/3 cascades to trigger T-cell Apoptosis and promote immune evasion. Notably, the finding indicated the non-redundant and synergistic effects of ACSS2 and AATF in modulating FasL expression, which might support emerging strategies for immunotherapy of PNETs.

Keywords

AATF; ACSS2; Acetyl‐CoA; Fas/FasL pathway; pancreatic neuroendocrine tumors.

Figures
Products
Inhibitors & Agonists